Doxazosin Mesylate
Doxazosin, a quinazoline-derivative, selectively antagonizes postsynaptic α1-adrenergic receptors, used in the treatment of high blood pressure and urinary retention associated with benign prostatic hyperplasia.
| Trivial name | N/A |
| Catalog Number | S1324 |
| Molecular Formula | C17H10N2O5 |
| CAS# | 77883-43-3 |
| Inchi | InChI=1S/C17H10N2O5/c20-17(14-7-8-16(24-14)19(21)22)18-10-5-6-12-11-3-1-2-4-13(11)23-15(12)9-10/h1-9H,(H,18,20) |
| Inchi Key | URUVDCCYSJEGQQ-UHFFFAOYSA-N |
| SMILES | C1=CC=C2C(=C1)C3=C(O2)C=C(C=C3)NC(=O)C4=CC=C(O4)[N+](=O)[O-] |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/Doxazosin-mesylate.html |
| Additional Information | https://file.selleck.cn/downloads/struct/Doxazosin-chemical-structure-S1324.gif |